Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Yael L. Maxwell

April 16, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Yael L. Maxwell

August 08, 2024

News Daily News

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

L.A. McKeown

May 24, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

L.A. McKeown

October 18, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Opinion CV Team Dispatch

June 2023 News Roundup

L.A. McKeown

June 01, 2023

News Conference News SCAI 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

L.A. McKeown

May 30, 2023

News Daily News

NSAIDs Tied to HF Hospitalization in Patients With Diabetes

L.A. McKeown

April 10, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

Caitlin E. Cox

January 14, 2022

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Opinion Fellow Talk

A Look Back at TCT 2018: What I Took Away From the Meeting

Yashasvi Chugh, MD

October 23, 2018

Advertisement

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

TCTMD’s Top 10 Most Popular Stories for January 2025

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

Semaglutide Winning Streak Continues in CKD With FLOW

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

CABG and PCI Comparable in ACS Patients With Left Main CAD

June 2023 News Roundup

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

NSAIDs Tied to HF Hospitalization in Patients With Diabetes

Vast Majority of HFrEF Patients Eligible for Vericiguat

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

Renal Function Gains Seen in CKD Patients After TAVR

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

A Look Back at TCT 2018: What I Took Away From the Meeting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content